Cargando…
Retention in the Austrian opioid agonist treatment system: a national prospective cohort study
BACKGROUND: Retention in care is a prerequisite for successful recovery, especially for a chronic condition like opioid dependence. Though retention varies greatly depending on the different substitution medication and treatment model, treatment retention is used as an indicator of treatment quality...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903033/ https://www.ncbi.nlm.nih.gov/pubmed/33627159 http://dx.doi.org/10.1186/s12954-021-00473-9 |
_version_ | 1783654658211840000 |
---|---|
author | Busch, Martin Klein, Charlotte Uhl, Alfred Haltmayer, Hans Cabanis, Maurice Westenberg, Jean Nicolas Vogel, Marc Krausz, R. Michael |
author_facet | Busch, Martin Klein, Charlotte Uhl, Alfred Haltmayer, Hans Cabanis, Maurice Westenberg, Jean Nicolas Vogel, Marc Krausz, R. Michael |
author_sort | Busch, Martin |
collection | PubMed |
description | BACKGROUND: Retention in care is a prerequisite for successful recovery, especially for a chronic condition like opioid dependence. Though retention varies greatly depending on the different substitution medication and treatment model, treatment retention is used as an indicator of treatment quality and effectiveness of care on a system and individual level. To monitor the overall quality of the Austrian opioid agonist treatment (OAT) system and to monitor patient satisfaction within the system, a new online-based registry called “eSuchmittel” was introduced in Austria at the beginning of 2011. The objective of this study is to analyze retention rates within the Austrian treatment system and to identify patient characteristics associated with retention, using data collected by the substitution registry. METHODS: The complete Austrian sample of 4778 registered patients starting treatment between 1.1.2011 to 31.12.2012 were included in the prospective cohort study using data from the Austrian substitution registry. For the statistical analysis, multivariate Cox Regression and Kaplan–Meier survival analysis were used to evaluate retention in treatment. RESULTS: The retention rate of the total cohort after two years was around 61%. Retention rates were significantly lower for men (exp(B) = .806, 95% CI 0.714–0.908) and significantly higher for patients aged 30 and older (exp(B) = 1.155, 95% CI 1.044–1.279), among patients located in Vienna (exp(B) = 1.439, 95% CI 1.273–1.626) and among patients prescribed oral slow-release morphine (SROM) (exp(B) = 2.141, 95% CI 1.885–2.430). CONCLUSIONS: Average retention in the Austrian system is high in comparison to international retention rates. Nationally, SROM demonstrates higher treatment retention when compared to other available substitution medications. Sociodemographic and regional indicators also contribute to higher retention in care. A systematic monitoring of retention rates within a national registry is an important tool helping to evaluate the quality of care. In this study, the Austrian OAT system proves very high retention in care, an important success criterion. |
format | Online Article Text |
id | pubmed-7903033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79030332021-02-24 Retention in the Austrian opioid agonist treatment system: a national prospective cohort study Busch, Martin Klein, Charlotte Uhl, Alfred Haltmayer, Hans Cabanis, Maurice Westenberg, Jean Nicolas Vogel, Marc Krausz, R. Michael Harm Reduct J Research BACKGROUND: Retention in care is a prerequisite for successful recovery, especially for a chronic condition like opioid dependence. Though retention varies greatly depending on the different substitution medication and treatment model, treatment retention is used as an indicator of treatment quality and effectiveness of care on a system and individual level. To monitor the overall quality of the Austrian opioid agonist treatment (OAT) system and to monitor patient satisfaction within the system, a new online-based registry called “eSuchmittel” was introduced in Austria at the beginning of 2011. The objective of this study is to analyze retention rates within the Austrian treatment system and to identify patient characteristics associated with retention, using data collected by the substitution registry. METHODS: The complete Austrian sample of 4778 registered patients starting treatment between 1.1.2011 to 31.12.2012 were included in the prospective cohort study using data from the Austrian substitution registry. For the statistical analysis, multivariate Cox Regression and Kaplan–Meier survival analysis were used to evaluate retention in treatment. RESULTS: The retention rate of the total cohort after two years was around 61%. Retention rates were significantly lower for men (exp(B) = .806, 95% CI 0.714–0.908) and significantly higher for patients aged 30 and older (exp(B) = 1.155, 95% CI 1.044–1.279), among patients located in Vienna (exp(B) = 1.439, 95% CI 1.273–1.626) and among patients prescribed oral slow-release morphine (SROM) (exp(B) = 2.141, 95% CI 1.885–2.430). CONCLUSIONS: Average retention in the Austrian system is high in comparison to international retention rates. Nationally, SROM demonstrates higher treatment retention when compared to other available substitution medications. Sociodemographic and regional indicators also contribute to higher retention in care. A systematic monitoring of retention rates within a national registry is an important tool helping to evaluate the quality of care. In this study, the Austrian OAT system proves very high retention in care, an important success criterion. BioMed Central 2021-02-24 /pmc/articles/PMC7903033/ /pubmed/33627159 http://dx.doi.org/10.1186/s12954-021-00473-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Busch, Martin Klein, Charlotte Uhl, Alfred Haltmayer, Hans Cabanis, Maurice Westenberg, Jean Nicolas Vogel, Marc Krausz, R. Michael Retention in the Austrian opioid agonist treatment system: a national prospective cohort study |
title | Retention in the Austrian opioid agonist treatment system: a national prospective cohort study |
title_full | Retention in the Austrian opioid agonist treatment system: a national prospective cohort study |
title_fullStr | Retention in the Austrian opioid agonist treatment system: a national prospective cohort study |
title_full_unstemmed | Retention in the Austrian opioid agonist treatment system: a national prospective cohort study |
title_short | Retention in the Austrian opioid agonist treatment system: a national prospective cohort study |
title_sort | retention in the austrian opioid agonist treatment system: a national prospective cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903033/ https://www.ncbi.nlm.nih.gov/pubmed/33627159 http://dx.doi.org/10.1186/s12954-021-00473-9 |
work_keys_str_mv | AT buschmartin retentionintheaustrianopioidagonisttreatmentsystemanationalprospectivecohortstudy AT kleincharlotte retentionintheaustrianopioidagonisttreatmentsystemanationalprospectivecohortstudy AT uhlalfred retentionintheaustrianopioidagonisttreatmentsystemanationalprospectivecohortstudy AT haltmayerhans retentionintheaustrianopioidagonisttreatmentsystemanationalprospectivecohortstudy AT cabanismaurice retentionintheaustrianopioidagonisttreatmentsystemanationalprospectivecohortstudy AT westenbergjeannicolas retentionintheaustrianopioidagonisttreatmentsystemanationalprospectivecohortstudy AT vogelmarc retentionintheaustrianopioidagonisttreatmentsystemanationalprospectivecohortstudy AT krauszrmichael retentionintheaustrianopioidagonisttreatmentsystemanationalprospectivecohortstudy |